InvestorsHub Logo
icon url

georgejjl

11/24/22 8:13 PM

#385012 RE: ExtremelyBullishZig #385010

The 509 participant actual sample size and the planned 450 participant sample size for the recently completed Anavex Phase 2b/3 trial is more than sufficient to achieve statistical significance for the endpoints given the expected effect sizes.

Blarcamesine has large to verily large effect sizes.

THAT IS A FACT!!!

GOD bless,